{"doi":"10.53350/pjmhs211592541","title":"Dyslipidemia in Chronic Kidney Disease","abstract":"<jats:p>Objective: To determine the frequency for pattern of dyslipidemia in patients with chronic kidney disease. Study Design: Descriptive, cross-sectional Place and Duration of Study: Department of Nephrology, Jinnah Postgraduate Medical Centre (JPMC) from 26th December 2018to 28thJune 2019. Methodology: One hundred and thirty-two patients were enrolled. Blood sample of 5 ml of each patient was taken and sent to the institutional pathology laboratory for measurement of lipid profile and pattern of dyslipidemia i.e. high cholesterol, low HDL, high LDL, hypertriglyceridemia was noted. Results: The mean age was 44.68±9.39 years and mean of duration of chronic kidney disease was 5.13±2.19 months. Seventy eight (59%) were males and 54 (41%) were females. Pattern of dyslipidemia i.e. high cholesterol, low HDL, high LDL and hypertriglyceridemia were documented in 89 (67.4%), 61 (46.2%), 65 (49.2%) and 37 (28.0%) patients respectively. Conclusion: Dyslipidemia is common among patients with chronic kidney disease is considerable. Regular evaluation of all chronic kidney disease patients for dyslipidemia and treatment need to be instituted. Key words: Dyslipidemia, Chronic kidney disease (CKD), Cholesterol, Low density lipoprotein (LDL), High density lipoprotein (HDL), Hypertriglyceridemia</jats:p>","journal":"Pakistan Journal of Medical and Health Sciences","year":2021,"id":639956,"datarank":0.10397207708399181,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"self_citation_contribution":0.10397207708399181,"citation_network_contribution":0.0,"self_endowment_contribution":0.10397207708399181,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1663061,"name":"Bhagwan Das","orcid":null,"position":1,"is_corresponding":false},{"id":270608,"name":"Santosh Kumar","orcid":"0000-0001-7846-5674","position":2,"is_corresponding":false},{"id":1663062,"name":"Abdul Manan Junejo","orcid":null,"position":3,"is_corresponding":false},{"id":1663063,"name":"Rafia Memon","orcid":null,"position":4,"is_corresponding":false},{"id":1663064,"name":"Sapna Bai","orcid":null,"position":5,"is_corresponding":false},{"id":1663060,"name":"Pardeep Sainani","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Dyslipidemia in Chronic Kidney Disease","abstract":"<jats:p>Objective: To determine the frequency for pattern of dyslipidemia in patients with chronic kidney disease. Study Design: Descriptive, cross-sectional Place and Duration of Study: Department of Nephrology, Jinnah Postgraduate Medical Centre (JPMC) from 26th December 2018to 28thJune 2019. Methodology: One hundred and thirty-two patients were enrolled. Blood sample of 5 ml of each patient was taken and sent to the institutional pathology laboratory for measurement of lipid profile and pattern of dyslipidemia i.e. high cholesterol, low HDL, high LDL, hypertriglyceridemia was noted. Results: The mean age was 44.68±9.39 years and mean of duration of chronic kidney disease was 5.13±2.19 months. Seventy eight (59%) were males and 54 (41%) were females. Pattern of dyslipidemia i.e. high cholesterol, low HDL, high LDL and hypertriglyceridemia were documented in 89 (67.4%), 61 (46.2%), 65 (49.2%) and 37 (28.0%) patients respectively. Conclusion: Dyslipidemia is common among patients with chronic kidney disease is considerable. Regular evaluation of all chronic kidney disease patients for dyslipidemia and treatment need to be instituted. Key words: Dyslipidemia, Chronic kidney disease (CKD), Cholesterol, Low density lipoprotein (LDL), High density lipoprotein (HDL), Hypertriglyceridemia</jats:p>","is_dataset_classified":null,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19767382","pmcid":null,"openalex_id":"https://openalex.org/W4386661715","authors":[],"funders":[],"total_grants":0,"fwci":0.2026,"citation_percentile":0.57059655,"influential_citations":0,"citation_trend":[{"year":2024,"count":1}],"oa_status":"gold","license":null,"oa_locations":[{"url":"https://pjmhsonline.com/2021/sep/2541.pdf","host_type":"journal"},{"url":"https://pjmhsonline.com/2021/sep/2541.pdf","host_type":"publisher"},{"url":"https://doi.org/10.53350/pjmhs211592541","host_type":"journal"}],"fields_of_study":["Lipoproteins and Cardiovascular Health","Cancer, Lipids, and Metabolism","Chronic Kidney Disease and Diabetes"],"mesh_terms":[],"keywords":["Dyslipidemia","Hypertriglyceridemia","Kidney disease","Medicine","Internal medicine","Nephrology","Gastroenterology","Lipid profile","Cholesterol","Disease","Triglyceride"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-07T04:58:41.795127Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}